Page 16 - IJB-2-1
P. 16

3D bioprinting for tissue engineering: Stem cells in hydrogels

            The introduction of cytotoxic crosslinking agents   stem cells which can be considered for 3D bioprinting:
            should be avoided and as cells are only able to survive   embryonic, somatic and iPSC.
            in  a narrow temperature range, the list of gel candi-  6.1.1 Embryonic Stem Cells (ESCs)
            dates is substantially reduced. However, by combining   With the ability to  form  any  cell type and  indefinite
            materials, the list of printable gels could once again be   self-renewal [99] , embryonic stem cells (ESCs) are the
            expanded.                                          ideal cell type for tissue engineering. One of the chal-
               Furthermore,  the  time  required  for  gelation  is of   lenges in using  ESCs for regenerating or repairing
            importance. The longer it takes for the material to be   tissue is identifying the conditions needed to drive the
            printed  and form the structure, the  more likely  the   cells towards a specific lineage. As cell differentiation
            layers printed at the start of the process will lose via-  is influenced by both chemical and physical cues, the
            bility,  thus  limiting  the  use  of  the  construct.  Other   identification of ideal culture conditions adds another
            factors include the introduction of stress on cells thr-  level of complexity to an already difficult task.
            ough changes in the viscosity of the gel. While control   The biggest drawback of using ESCs is that they
            of viscosity would make the gel more printable, slight   are derived  from  a blastocyst. In  some countries,
            changes  could lead to low  cell viability  rates. Stress   ESCs research is prohibited or severely restricted due
            could also be introduced by methods of extruding the   to  the ethical issues this raises. Furthermore, where
            bioink [36]  and changes in temperature during the prin-  research in the field is allowed, the number of cells
            ting process, although the latter is dependent on how   derived from an embryonic source is low and, unless
            long high temperatures are maintained. In their study,   expanded significantly  in  vitro, is unlikely to  meet
            Cui  et al. [16]   reported a rise in temperature during   clinical demand.
            printing from 22°C  to 46°C. However, as the  drops   6.1.2 Adult Stem Cells
            produced cooled within seconds, no significant apop-  Adult stem cells cover any postnatal somatic cell that
            tosis was observed.                                is undifferentiated and can self-renew [100] . These cells
            6. Using Stem Cells for 3D Bioprinting             can be derived from a number of sources including
                                                               brain, liver and bone marrow [101] . Mesenchymal stem
            The ideal cell type for bioprinting is dependent on the   cells (MSCs) are readily available from bone marrow,
            accessibility and availability of the cells, the self-ren-  adipose tissue, amniotic fluid, the synovium  and pe-
            ewal  and expansion capacity, differentiation profile   riosteum and are known to be less tumorigenic than
            and  cellular tumorigenicity  as well as viability fol-  their embryonic or fetal  counterparts [98] . MSCs are
            lowing encapsulation and printing. Stem  cells  are a   non-haematopoietic, are relatively straightforward  to
            particularly attractive cell type as they are pluripotent   obtain via bone  marrow harvesting  methods [102]   and
            and able to differentiate into other cell types upon ex-  interact well with  a range of materials that  may be
            posure to the correct physical and chemical guidance   used for cellular encapsulation to produce viable bio-
            cues [93] . Within the human body, there are a number of   inks. Table 1 features the types of adult MSCs which
            viable sources of stem cells, such as the bone marrow,   have been used for bioprinting applications.
            periosteum and adipose tissue [94–96] .              Although MSCs can be harvested from the patient’s
                                                               own tissue, and therefore reduce the risk of rejection,
            6.1 Stem Cells Selection
                                                               only 0.001%–0.01% of total nucleated cells in bone
            Stem  cell differentiation can be guided through the   marrow  are MSCs [102] . A possible alternative source
            incorporation of tissue-specific chemical signals in the   which could be used is adipose derived MSCs
            scaffold, although some researchers suggest that this   (ADMSCs). Adipose tissue is abundant and many re-
            may not be necessary to promote differentiation  and   searchers  have  used  ADMSCs  successfully  towards
            subsequent tissue regeneration [97] .  While the advan-  tissue engineering [94,103,104] .
            tages of using pluripotent cells in bioprinting are clear,   6.1.3 Induced Pluripotent Stem Cells (iPSC)
            there are  ethical considerations  which  must be taken   The discovery that stem cells can be generated directly
            into account when using stem cells. Furthermore, the   from adult cells by the introduction of four transcription
            generation of  pluripotent stem cells from adult cells   factors has revolutionised biomedical research [105–108] .
            (induced pluripotent stem cells, iPSC) pose the risk of   By  using  the  patient’s  own  cells,  the  ethical issues
            tumorigenicity which must also be considered [98] . Eth-  related to stem cell research and the concern sur-
            ical issues aside, there are three  main  categories of   rounding tissue rejection can be avoided. Furthermore,

            12                          International Journal of Bioprinting (2016)–Volume 2, Issue 1
   11   12   13   14   15   16   17   18   19   20   21